UnknownNot Applicable

OCTA Changes in Choroidal Neovascularization in High Myopia

100 participantsStarted 2024-04-30

Plain-language summary

To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV..

Who can participate

Age range10 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All Patients with High Myopia ( \> -6 D or Axial Length \> 26.5 mm ) with Fundoscopic Changes Consistent with CNVM , with Clear Media are Subjected to OCTA Exclusion Criteria: * Patients with Treated CNVs , or with other Causes of CNVs including : Neovascular AMD , Idiopathic CNV , Traumatic , Inflammatory , Neoplastic , Degenerative ..

What they're measuring

Describing the Choroidal Neovascularization in High Myopic Patients diagnosed by OCTA

Timeframe: 1 year

Trial details

NCT IDNCT06357559

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-15

Contact for this trial

Ahmed Hamdy

01287307536 fcb9976@Gmail.com

View on ClinicalTrials.gov More Myopic Choroidal Neovascularisation trials